Saniona AB: Saniona Announces Refocused Strategy on Ion Channel R&D and Restructuring of Board of Directors and Executive Management Team

PRESS RELEASE April 25, 2022 Jørgen Drejer, co-founder and board member, appointed interim Chairman of the Board of Directors; Thomas Feldthus, co-founder, appointed as CEO; Anita Milland

Related Keywords

Denmark ,Copenhagen ,Køavn ,Stockholm ,Sweden ,Edwardc Saltzman ,Anna Ljung ,Anita Milland ,Thomas Feldthus ,Carl Johan Sundberg ,Roberte Hoffman ,Karin Sandager Nielsen ,Nomination Committee ,Parent Company ,Saniona Group ,Chief Executive Officer ,Chief Financial Officer ,Annual General Meeting ,Nominating Committee ,Year End Report ,Annual Report ,Rami Levin ,Investigational New Drug ,Channel Drug Discovery Engine ,Chief Scientific ,Sandager Nielsen ,Senior Vice President In Vivo ,Translational Pharmacology ,Abuse Regulation This ,Nasdaq Stockholm Small ,Saniona ,Nnounces ,Defocused ,Strategy ,Channel ,Restructuring ,Board ,Directors ,Executive ,Management ,Team ,